Continuous temperature monitoring for the detection of fever in haemato-oncology patients: a pilot study of two wearable devices (THERMAL)

This pilot study explored the acceptability and feasibility of two continuous temperature monitoring devices, CORE® and TempTraq®, in 15 inpatients at risk of neutropenic fever (NF) or cytokine release syndrome (CRS) after chemotherapy, stem cell transplant or chimeric antigen receptor (CAR) T cells. Each device was worn for a median of ≥95% of the study, correlated with tympanic temperature and exhibited potential for early detection of NF or CRS (ClinicalTrials.gov NCT05203809).